MersV1, PubMed, Checkpoint, bibRecord, 001E66

2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.

Identifieur interne : 001E66 ( PubMed/Checkpoint ); précédent : 001E65; suivant : 001E67

2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.

Auteurs : Ludovic Akonan ; Kouassi Yves Guillaume Molou ; Adjo Adohi-Krou ; Akoun Abou ; Abodou Jules Tenon

Source :

Acta crystallographica. Section E, Structure reports online [ 1600-5368 ] ; 2010.

RBID : pubmed:21579857

Abstract

In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å.

DOI: 10.1107/S1600536810001960
PubMed: 21579857

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001F77
to stream PubMed, to step Curation: 001F77

Links to Exploration step

pubmed:21579857

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.</title>
<author><name sortKey="Akonan, Ludovic" sort="Akonan, Ludovic" uniqKey="Akonan L" first="Ludovic" last="Akonan">Ludovic Akonan</name>
</author>
<author><name sortKey="Molou, Kouassi Yves Guillaume" sort="Molou, Kouassi Yves Guillaume" uniqKey="Molou K" first="Kouassi Yves Guillaume" last="Molou">Kouassi Yves Guillaume Molou</name>
</author>
<author><name sortKey="Adohi Krou, Adjo" sort="Adohi Krou, Adjo" uniqKey="Adohi Krou A" first="Adjo" last="Adohi-Krou">Adjo Adohi-Krou</name>
</author>
<author><name sortKey="Abou, Akoun" sort="Abou, Akoun" uniqKey="Abou A" first="Akoun" last="Abou">Akoun Abou</name>
</author>
<author><name sortKey="Tenon, Abodou Jules" sort="Tenon, Abodou Jules" uniqKey="Tenon A" first="Abodou Jules" last="Tenon">Abodou Jules Tenon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:21579857</idno>
<idno type="pmid">21579857</idno>
<idno type="doi">10.1107/S1600536810001960</idno>
<idno type="wicri:Area/PubMed/Corpus">001F77</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F77</idno>
<idno type="wicri:Area/PubMed/Curation">001F77</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F77</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001E66</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E66</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.</title>
<author><name sortKey="Akonan, Ludovic" sort="Akonan, Ludovic" uniqKey="Akonan L" first="Ludovic" last="Akonan">Ludovic Akonan</name>
</author>
<author><name sortKey="Molou, Kouassi Yves Guillaume" sort="Molou, Kouassi Yves Guillaume" uniqKey="Molou K" first="Kouassi Yves Guillaume" last="Molou">Kouassi Yves Guillaume Molou</name>
</author>
<author><name sortKey="Adohi Krou, Adjo" sort="Adohi Krou, Adjo" uniqKey="Adohi Krou A" first="Adjo" last="Adohi-Krou">Adjo Adohi-Krou</name>
</author>
<author><name sortKey="Abou, Akoun" sort="Abou, Akoun" uniqKey="Abou A" first="Akoun" last="Abou">Akoun Abou</name>
</author>
<author><name sortKey="Tenon, Abodou Jules" sort="Tenon, Abodou Jules" uniqKey="Tenon A" first="Abodou Jules" last="Tenon">Abodou Jules Tenon</name>
</author>
</analytic>
<series><title level="j">Acta crystallographica. Section E, Structure reports online</title>
<idno type="eISSN">1600-5368</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">21579857</PMID>
<DateCompleted><Year>2011</Year>
<Month>07</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1600-5368</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>66</Volume>
<Issue>Pt 2</Issue>
<PubDate><Year>2010</Year>
<Month>Jan</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Acta crystallographica. Section E, Structure reports online</Title>
<ISOAbbreviation>Acta Crystallogr Sect E Struct Rep Online</ISOAbbreviation>
</Journal>
<ArticleTitle>2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.</ArticleTitle>
<Pagination><MedlinePgn>o442</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1107/S1600536810001960</ELocationID>
<Abstract><AbstractText>In the title compound, C(10)H(12)N(2)OS, the asymmetric unit consists of two independent mol-ecules. In the crystal structure, mol-ecules form R(4) (4)(28) centrosymmetric tetra-mers via O-H⋯N hydrogen bonds. These tetra-mers are stacked along the c axis via C-H⋯O hydrogen bonds. C-H⋯π and π-π inter-actions are also present; in the latter, the centroid-centroid distances are 4.075 (1) and 3.719 (1) Å.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akonan</LastName>
<ForeName>Ludovic</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Molou</LastName>
<ForeName>Kouassi Yves Guillaume</ForeName>
<Initials>KY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Adohi-Krou</LastName>
<ForeName>Adjo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Abou</LastName>
<ForeName>Akoun</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tenon</LastName>
<ForeName>Abodou Jules</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>01</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Acta Crystallogr Sect E Struct Rep Online</MedlineTA>
<NlmUniqueID>101089178</NlmUniqueID>
<ISSNLinking>1600-5368</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>12</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2010</Year>
<Month>01</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21579857</ArticleId>
<ArticleId IdType="doi">10.1107/S1600536810001960</ArticleId>
<ArticleId IdType="pmc">PMC2979779</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Farmaco. 2003 Jun;58(6):431-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12767382</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19171970</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chem Pharm Bull (Tokyo). 2008 Mar;56(3):273-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18310935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arzneimittelforschung. 2004;54(1):64-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14979611</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Abou, Akoun" sort="Abou, Akoun" uniqKey="Abou A" first="Akoun" last="Abou">Akoun Abou</name>
<name sortKey="Adohi Krou, Adjo" sort="Adohi Krou, Adjo" uniqKey="Adohi Krou A" first="Adjo" last="Adohi-Krou">Adjo Adohi-Krou</name>
<name sortKey="Akonan, Ludovic" sort="Akonan, Ludovic" uniqKey="Akonan L" first="Ludovic" last="Akonan">Ludovic Akonan</name>
<name sortKey="Molou, Kouassi Yves Guillaume" sort="Molou, Kouassi Yves Guillaume" uniqKey="Molou K" first="Kouassi Yves Guillaume" last="Molou">Kouassi Yves Guillaume Molou</name>
<name sortKey="Tenon, Abodou Jules" sort="Tenon, Abodou Jules" uniqKey="Tenon A" first="Abodou Jules" last="Tenon">Abodou Jules Tenon</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E66 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001E66 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:21579857
   |texte=   2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:21579857" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.

2-[2-(Methyl-sulfan-yl)benzimidazol-1-yl]ethanol.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki